Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in elderly women with epithelial ovarian cancer: analysis of a prospective registry.
Laura M ChambersMeng YaoMolly MortonAnna ChichuraAnthony B CostalesMax HorowitzMorgan F GrunerPeter G RoseChad M MichenerRobert DeBernardoPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2021)
In this prospective registry of women with ovarian cancer, perioperative morbidity is not increased for non-elderly versus elderly patients following surgery with HIPEC. While age should not exclude patients from surgery with HIPEC, additional research is needed regarding oncologic benefits in elderly women.
Keyphrases
- minimally invasive
- coronary artery bypass
- middle aged
- end stage renal disease
- surgical site infection
- community dwelling
- cardiac surgery
- patients undergoing
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prostate cancer
- robot assisted
- polycystic ovary syndrome
- radiation therapy
- metabolic syndrome
- rectal cancer
- peritoneal dialysis
- pregnant women
- skeletal muscle
- locally advanced
- weight loss